Apolipoprotein A-I Supports MSCs Survival under Stress Conditions.

Svetlana Miroshnichenko, Ivan Usynin, Alexey Dudarev, Vadim Nimaev, Anastasiya Solovieva

International journal of molecular sciences 2020 Jun 05

filter terms:

Clinical trials have shown the safety of mesenchymal stem/stromal cells (MSCs) transplantation, but the effectiveness of these treatments is limited. Since, transplanted MSCs will undergo metabolic disturbances in the bloodstream, we investigated the influence of blood plasmas of type 2 diabetes (T2D) patients on MSCs viability and examined whether apolipoprotein A-I (apoA-I) could protect cells from stressful conditions of serum deprivation (SD), hypoxia, and elevated concentrations of reactive oxygen species (ROS). ApoA-I exhibits anti-inflammatory, immune activities, improves glycemic control, and is suitable for T2D patients but its influence on MSCs remains unknown. For the first time we have shown that apoA-I decreases intracellular ROS and supports proliferative rate of MSCs, thereby increasing cell count in oxidation conditions. ApoA-I did not influence cell cycle when MSCs were predominantly in the G0/G1 phases under conditions of SD/hypoxia, activated proliferation rapidly, and reduced apoptosis during MSCs transition to the oxygenation or oxidation conditions. Finally, it was found that the blood plasma of T2D individuals had a cytotoxic effect on MSСs in 39% of cases and had a wide variability of antioxidant properties. ApoA-I protects cells under all adverse conditions and can increase the efficiency of MSCs transplantation in T2D patients.

Citation

Svetlana Miroshnichenko, Ivan Usynin, Alexey Dudarev, Vadim Nimaev, Anastasiya Solovieva. Apolipoprotein A-I Supports MSCs Survival under Stress Conditions. International journal of molecular sciences. 2020 Jun 05;21(11)